Yifan Pharmaceutical Co., Ltd. is a high-risk company in the Pharmaceuticals industry based in China. Specializing in pharmaceutical innovation and manufacturing, the company focuses on areas such as macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. Their products, including F-627, F-652, and F-899, cater to various health conditions and are sold both domestically and internationally. With an ESG score of 34.1, Yifan Pharmaceutical Co., Ltd. is a player in the industry to watch out for.